The Centre for Bioinformatics, Biomarker Discovery and Information-Based Medicine (CIBM) is committed to shortening the process of obtaining novel discoveries to achieve distinctively better outcomes in clinical practice and translational individualised medicine.
A scientific revolution is in the making. In a few years time, all known genetic risk factors for diseases could be routinely determined at birth. Using large-scale molecular interrogation methods, powered by advances in mathematics and computer science, a patient's particular disease subtypes could be identified and the best available treatment selected. Outcomes of patient tailored treatments will be valuable for the development of new diagnostic approaches and drug designs that specifically target aberrant molecular pathways present in diseased cells with minimal interference on healthy ones. This is the promise of personalised information-based medicine.
The core aim of the research conducted by this Centre is the delivery of "bench-to-bedside" research by combining the often disparate disciplines of bioinformatics, molecular and genetic analysis, clinical information and population data. The Centre for Bioinformatics, Biomarker Discovery & Information-Based Medicine (CIBM) aims to find methodologies that will shorten the process of obtaining novel discoveries and to use them to obtain distinctively better outcomes in clinical practice and translational individualised medicine.
In an interview to CBS News, Dr. Anna Barker, former Deputy Director of the National Cancer Institute (U.S.A), explains in simple terms the basics of Bioinformatics and its applications to Cancer Research.